Healthcare -
Biotechnology - NASDAQ - US
$ 4.39
-1.84 %
$ 37.9 M
Market Cap
-0.36
P/E
KPTI - OPERATING INCOME
Operating Income KPTI - Karyopharm Therapeutics Inc.
-119 M
LAST VALUE
8.35%
2 YEAR CAGR
8.80%
5 YEAR CAGR
-4.65%
10 YEAR CAGR